In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1715 News Items found
MSK neuro-oncologist Ingo Mellinghoff
FDA Approves Drug for Low-Grade Glioma With IDH Gene Mutation

A new drug could be an effective treatment for some people with low-grade glioma.
MSK case manager Mercedes Tolentino-Nacion
The Unsung Heroes of Cancer Care: Getting Patients What They Need When They Go Home

Learn how case managers play an essential role in making sure patients are supported when they leave the hospital for home.
In the Clinic
Dr. Sandra D'Angelo
FDA Approves First Engineered Cell Therapy for Treating Rare Sarcoma

The FDA has approved an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials resulting in the drug’s approval were led by Dr. Sandra D’Angelo of MSK.
MSK lab coat
MSK Researchers Discover Source of Deadly Fungal Infections in Bone Marrow Transplant Patients, New Study Finds

A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients.
Article
MSK hematologic oncologist Lia Palomba talking to patient.
FDA Approves CAR T Cell Treatment for Resistant Mantle Cell Lymphoma

Learn how MSK researchers led the way in the approval of a new mantle cell lymphoma CAR T cell treatment.
Detail shot of a scientist purifying proteins
MSK Research Highlights, July 31, 2024

New MSK research showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.
Grace Yang reclines in a hospital bed and holds a bag of stem cells.
Donating Bone Marrow and Stem Cells: The Process and What To Expect

Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.
Dr. Jun Mao performs acupuncture
Acupuncture for Neuropathy, Cancer Pain, Anxiety, and More

Learn about the latest research on acupuncture from MSK and how our investigators are studying the benefits of acupuncture for relieving the side effects of cancer and its therapies.
MSK exercise scientist Lee Jones, PhD, is seen in a gym.
Can Exercise Impact Prostate Cancer? A First of its Kind Clinical Trial

Learn how exercise may affect the treatment of prostate cancer, in a first of its kind clinical trial at Memorial Sloan Kettering Cancer Center.
Andrea Schietinger
Better Together: Spatial Arrangement of Three Immune Cells Is Key to Attacking Tumors

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.